353 related articles for article (PubMed ID: 15272145)
1. Erythropoietin as a novel neuroprotectant.
Genc S; Koroglu TF; Genc K
Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin and the nervous system.
Genc S; Koroglu TF; Genc K
Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F
Brain Res Rev; 2008 Nov; 59(1):22-33. PubMed ID: 18514916
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietin--a new therapy in cerebral ischemia?].
Kalialis LV; Olsen NV
Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin: a novel neuroprotective cytokine.
Bartesaghi S; Marinovich M; Corsini E; Galli CL; Viviani B
Neurotoxicology; 2005 Oct; 26(5):923-8. PubMed ID: 15927257
[TBL] [Abstract][Full Text] [Related]
6. The use of erythtropoietin in cerebral diseases.
Cotena S; Piazza O; Tufano R
Panminerva Med; 2008 Jun; 50(2):185-92. PubMed ID: 18607342
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as an antiapoptotic, tissue-protective cytokine.
Ghezzi P; Brines M
Cell Death Differ; 2004 Jul; 11 Suppl 1():S37-44. PubMed ID: 15243580
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia.
Spandou E; Soubasi V; Papoutsopoulou S; Karkavelas G; Simeonidou C; Kaiki-Astara A; Guiba-Tziampiri O
Neurosci Lett; 2004 Aug; 366(1):24-8. PubMed ID: 15265583
[TBL] [Abstract][Full Text] [Related]
9. The role of erythropoietin in neuroprotection: therapeutic perspectives.
Grasso G; Sfacteria A; Meli F; Passalacqua M; Fodale V; Buemi M; Giambartino F; Iacopino DG; Tomasello F
Drug News Perspect; 2007 Jun; 20(5):315-20. PubMed ID: 17878959
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system frontiers for the use of erythropoietin.
Olsen NV
Clin Infect Dis; 2003; 37 Suppl 4():S323-30. PubMed ID: 14582001
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and neuroprotection: a therapeutic perspective.
Milano M; Collomp R
J Oncol Pharm Pract; 2005 Dec; 11(4):145-9. PubMed ID: 16595066
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin in neonatal brain protection: the past, the present and the future.
Kumral A; Tüzün F; Oner MG; Genç S; Duman N; Ozkan H
Brain Dev; 2011 Sep; 33(8):632-43. PubMed ID: 21109375
[TBL] [Abstract][Full Text] [Related]
15. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
Jelkmann W; Wagner K
Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
17. The erythropoietin receptor and its expression in tumor cells and other tissues.
Farrell F; Lee A
Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus.
Nadam J; Navarro F; Sanchez P; Moulin C; Georges B; Laglaine A; Pequignot JM; Morales A; Ryvlin P; Bezin L
Neurobiol Dis; 2007 Feb; 25(2):412-26. PubMed ID: 17166730
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
